Back to search
FDAFDA · Food and drugs·Recall number D-0500-2025

KETAmine Hydrochloride Injection, USP, 50 mg/5mL (10 mg/mL), For IM Use or Slow IV Use, 5 mL Sterile Single-Dose Vial, Rx Only, For Office Use Only, Compounded Durg by: Medivant Healthcare, 158 S. Kyrene Rd. Chandler, AZ 85226, NDC 81483-0006-0.

Published July 9, 2025 · Recall initiated: June 2, 2025

Summary

FDA records drug Class II recall D-0500-2025, published July 9, 2025 and initiated June 2, 2025. Recalling firm: Tailstorm Health INC; Status: Ongoing; Reported quantity: 23,200 vials; Lot: Lot #s: 2502008, Exp. 2/27/2027; 2503001, Exp. 3/4/2027. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lack of Assurance of Sterility: A recent FDA inspection revealed concerns with the sterile manufacturing process.

What to do

Voluntary: Firm initiated

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Tailstorm Health INC
Distributor
Nationwide in the US
Lot
Lot #s: 2502008, Exp. 2/27/2027; 2503001, Exp. 3/4/2027.
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was KETAmine Hydrochloride Injection, USP, 50 mg/5mL (10 mg/mL), For IM Use or Slow IV Use, 5 mL Sterile Single-Dose Vial, Rx Only, For Office Use Only, Compounded Durg by: Medivant Healthcare, 158 S. Kyrene Rd. Chandler, AZ 85226, NDC 81483-0006-0. recalled?

Yes. FDA published recall D-0500-2025 on July 9, 2025. Reported hazard: Lack of Assurance of Sterility: A recent FDA inspection revealed concerns with the sterile manufacturing process.

What should I do if I have this product?

Voluntary: Firm initiated